Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH

Watchlist Manager
Fisher & Paykel Healthcare Corporation Ltd Logo
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
Watchlist
Price: 38.55 NZD 4.3% Market Closed
Market Cap: 22.6B NZD
Have any thoughts about
Fisher & Paykel Healthcare Corporation Ltd?
Write Note

Fisher & Paykel Healthcare Corporation Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fisher & Paykel Healthcare Corporation Ltd
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
Operating Expenses
-NZ$691m
CAGR 3-Years
-9%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Truscreen Group Ltd
NZX:TRU
Operating Expenses
-NZ$2.7m
CAGR 3-Years
10%
CAGR 5-Years
5%
CAGR 10-Years
N/A
No Stocks Found

Fisher & Paykel Healthcare Corporation Ltd
Glance View

Market Cap
22.5B NZD
Industry
Health Care

Fisher & Paykel Healthcare Corporation Ltd., a leading provider of innovative medical devices and respiratory products, has carved a prominent niche in the global healthcare market. Founded in New Zealand in 1934, the company has evolved from a humble appliance manufacturer into a key player in respiratory care and sleep medicine. With a mission centered on improving patient outcomes, Fisher & Paykel leverages its strong research and development capabilities to create state-of-the-art products, such as its award-winning humidifiers and nasal mask systems, designed to support patients with respiratory issues and obstructive sleep apnea. The company boasts a diverse international presence, with a robust distribution network that allows it to serve healthcare professionals and patients in over 120 countries. For investors, Fisher & Paykel stands out not only for its continual focus on innovation but also for its stable financial performance. Throughout its history, the company has demonstrated resilience and adaptability, adeptly navigating market fluctuations and healthcare trends. With a strong balance sheet, a consistent track record of revenue growth, and a commitment to shareholder returns, Fisher & Paykel is well-positioned for future expansion, particularly as global healthcare demands rise. As the aging population and the increasing prevalence of chronic respiratory conditions drive market growth, investors may find Fisher & Paykel Healthcare a compelling opportunity, with its blend of innovative solutions and solid financial foundations paving the way for sustained success.

FPH Intrinsic Value
23.16 NZD
Overvaluation 40%
Intrinsic Value
Price

See Also

What is Fisher & Paykel Healthcare Corporation Ltd's Operating Expenses?
Operating Expenses
-691m NZD

Based on the financial report for Mar 31, 2024, Fisher & Paykel Healthcare Corporation Ltd's Operating Expenses amounts to -691m NZD.

What is Fisher & Paykel Healthcare Corporation Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-10%

Over the last year, the Operating Expenses growth was -14%. The average annual Operating Expenses growth rates for Fisher & Paykel Healthcare Corporation Ltd have been -9% over the past three years , -10% over the past five years .

Back to Top